Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Physician
Patient
Health Care Practitioner
Pharma / Biotech Industry
Other
Topics:
Vaccines
•
Allergy & Immunology
•
Primary Care
Does splitting the dose of a vaccine during an observed administration affect the efficacy of the vaccine response?
Related Questions
Do patients with a PEG allergy have a contraindication to receiving mRNA vaccines?
How long do you counsel patients to wait after rituximab therapy before getting live vaccines?
Do mRNA vaccines lead to increased rates of acute/chronic urticaria?
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
When would you recommend prescribing an asthmatic patient budesonide/salbutamol rather than budesonide/formoterol?
Do you look for local IgE production in the nares with negative SPT and IgE testing if the clinical history suggests AR and the patient desires AIT?
When do you consider extending the dosing interval for patients on biologics with CRSwNP?
Do you give additional pneumococcal vaccines after a dose of PCV20 in patients with asplenia?
How do you manage recurrent epistaxis from nasal steroids?
What medications do you counsel patients to avoid if they develop ACEi angioedema?
